Brought to you by 
Pharmion nets $238.1mm with FOPO
06 Jul 2004
Executive Summary
Pharmion Corp. (hematology and cancer therapeutics) sold 5.29mm shares of common stock (including the overallotment) at $48 each in a follow-on public offering for net proceeds of $238.1mm. The company originally planned to sell 4mm shares at $38.79mm each.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Pharmion nets $238.1mm with FOPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice